Defining low and undetectable levels of disease in chronic myeloid leukemia:progress towards standardisation in Europe

Autor: H. White, F. Lin, A. Aggerholm, H. Andrikovics, G. Barbany, N. Boeckx, J. M. Cayuela, D. Colomer, F. Daraio, S. Dulucq, H. El Housni, G. Gerrard, E. Gineikiene, S. Hayette, M. Jansson, P. Johnels, T. Jurcek19, V. Kairisto20, T. Lange21, T. Lion22, K. Machova23, G. Martinelli, PA Merle, G. Mitterbauer Hohendanner, M. Nagar Marciano, J. Nomdedeu, D. A. Nymoen, E. Oppliger Leibundgut, U. Ozbek, T. Pajic, C. Preudhomme33, K. Raudsepp34, T. Sacha35, R. Talmaci36, T. Touloumenidou, VHJ Van der Velden, R. Zadro, J. Ziermann, K. Zoi, MC Müller, A. Hochhaus, NCP Cross, IZZO, BARBARA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3730::a07e071d43897f4718aad7c148a45321
http://hdl.handle.net/11588/598800

DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemia.

Autor: Cucchi DGJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and., Vonk CM; Department of Hematology, Erasmus Medical Center Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Rijken M; Department of Hematology, Erasmus Medical Center Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Kavelaars FG; Department of Hematology, Erasmus Medical Center Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Merle PA; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and., Verhoef E; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and., Venniker-Punt B; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and., Kwidama ZJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and., Gradowska P; Department of Hematology, Erasmus Medical Center Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Löwenberg B; Department of Hematology, Erasmus Medical Center Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Janssen JJWM; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and., Cloos J; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and., Valk PJM; Department of Hematology, Erasmus Medical Center Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Publikováno v: Blood advances [Blood Adv] 2021 Nov 09; Vol. 5 (21), pp. 4476-4479.

A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR.

Autor: White H; 1] National Genetics Reference Laboratory (Wessex), Salisbury District Hospital, Salisbury, UK [2] Faculty of Medicine, University of Southampton, Southampton, UK., Deprez L; European Commission, Joint Research Centre, Institute for Reference Materials and Measurements, Geel, Belgium., Corbisier P; European Commission, Joint Research Centre, Institute for Reference Materials and Measurements, Geel, Belgium., Hall V; National Genetics Reference Laboratory (Wessex), Salisbury District Hospital, Salisbury, UK., Lin F; 1] National Genetics Reference Laboratory (Wessex), Salisbury District Hospital, Salisbury, UK [2] Faculty of Medicine, University of Southampton, Southampton, UK., Mazoua S; European Commission, Joint Research Centre, Institute for Reference Materials and Measurements, Geel, Belgium., Trapmann S; European Commission, Joint Research Centre, Institute for Reference Materials and Measurements, Geel, Belgium., Aggerholm A; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark., Andrikovics H; Hungarian National Blood Transfusion Service, Budapest, Hungary., Akiki S; Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK., Barbany G; Department of Molecular Medicine and Surgery, Clinical Genetics Karolinska Institutet, Stockholm, Sweden., Boeckx N; 1] Department of Laboratory Medicine, UZ Leuven, Belgium [2] Department of Oncology, KU Leuven, Belgium., Bench A; Molecular Malignancy Laboratory and Haemato-Oncology Diagnostic Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Catherwood M; Haematology Department, Belfast City Hospital, Belfast, UK., Cayuela JM; Haematology Laboratory and EA3518, University Hospital Saint-Louis, AP-HP, University Paris Diderot, Paris, France., Chudleigh S; Department of Molecular Haematology, Yorkhill NHS Trust, Glasgow, UK., Clench T; Molecular Haematology, Bristol Royal Infirmary, Bristol, UK., Colomer D; Hematopathology Unit, Hospital Clinic, IDIBAPS, Barcelona, Spain., Daraio F; Department of Clinical and Biological Science, University of Turin, Turin, Italy., Dulucq S; Laboratoire Hematologie, CHU Bordeaux, Hematopoiese Leucemique et Cibles Therapeutiques, INSERM U1035, Universite Bordeaux, Bordeaux, France., Farrugia J; Combined Laboratories, Derriford Hospital, Plymouth, UK., Fletcher L; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia., Foroni L; Imperial Molecular Pathology, Centre for Haematology, Imperial College London, London, UK., Ganderton R; Molecular Pathology, University Hospitals Southampton NHS Foundation Trust, Southampton, UK., Gerrard G; Imperial Molecular Pathology, Centre for Haematology, Imperial College London, London, UK., Gineikienė E; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania., Hayette S; Laboratory of Molecular Biology and UMR5239, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite, France., El Housni H; Medical Genetics Department, Erasme Hospital, Brussels, Belgium., Izzo B; Department of Clinical Medicine and Surgery, University 'Federico II' of Naples, Naples, Italy., Jansson M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Johnels P; Department of Clinical Genetics, University and Regional Laboratories, Lund, Sweden., Jurcek T; Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic., Kairisto V; Turku University Hospital, TYKSLAB, Laboratory of Molecular Genetics, Turku, Finland., Kizilors A; Laboratory for Molecular Haemato-Oncology, Kings College Hospital, London, UK., Kim DW; Cancer Research Institute, The Catholic University of Korea, Seoul, South Korea., Lange T; Abteilung für Hämatologie und internistische Onkologie, Universität Leipzig, Leipzig, Germany., Lion T; Children's Cancer Research Institute/LabDia Labordiagnostik and Medical University, Vienna, Austria., Polakova KM; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Martinelli G; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy., McCarron S; Cancer Molecular Diagnostics, St James's Hospital, Dublin, Ireland., Merle PA; VU Medical Centre, Department of Haematology, Amsterdam, The Netherlands., Milner B; Department of Medical Genetics, NHS-Grampian, Aberdeen, UK., Mitterbauer-Hohendanner G; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Nagar M; Laboratory of Hematology, Sheba Medical Center, Tel Hashomer, Israel., Nickless G; Molecular Oncology Diagnostics Unit, Guy's Hospital, London, UK., Nomdedéu J; Lab Hematologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Nymoen DA; Division of Pathology, Rikshospital, Oslo University Hospital, Oslo, Norway., Leibundgut EO; Molecular Diagnostics Laboratory, Department of Hematology, University Hospital Bern, Bern, Switzerland., Ozbek U; Genetics Department, Institute of Experimental Medicine (DETAE), Istanbul University, Istanbul, Turkey., Pajič T; Specialized Haematology Laboratory, Division of Internal Medicine, Department of Haematology, University Medical Centre, Ljubljana, Slovenia., Pfeifer H; Department of Internal Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany., Preudhomme C; Laboratoire d'hématologie, CHU Lille, Lille, France., Raudsepp K; United Laboratories of Tartu University Hospitals, Tartu, Estonia., Romeo G; Molecular Haematology Laboratory, PathWest Laboratory Medicine, Royal Perth Hospital, Perth, WA, Australia., Sacha T; Hematology Department, Jagiellonian University, Krakow, Poland., Talmaci R; Hematology Department, Fundeni Clinical Institute, University of Medicine and Pharmacy 'Carol Davila', Bucharest, Romania., Touloumenidou T; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Van der Velden VH; Department of Immunology, Erasmus MC, Rotterdam, The Netherlands., Waits P; Bristol Genetics Laboratory, Southmead Hospital, Bristol, UK., Wang L; Department of Haematology, Royal Liverpool University Hospital, Liverpool, UK., Wilkinson E; HMDS, Leeds Institute of Oncology, St James's University Hospital, Leeds, UK., Wilson G; Sheffield Diagnostic Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK., Wren D; Molecular Diagnostics, The Royal Marsden NHS Foundation Trust, Sutton, UK., Zadro R; Department of Laboratory Diagnostics, Clinical Hospital Center, Zagreb University School of Medicine, Zagreb, Croatia., Ziermann J; Department of Hematology/Oncology, Jena University Hospital, Jena, Germany., Zoi K; Haematology Research Laboratory, Biomedical Research Foundation, Academy of Athens, Athens, Greece., Müller MC; III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany., Hochhaus A; Department of Hematology/Oncology, Jena University Hospital, Jena, Germany., Schimmel H; European Commission, Joint Research Centre, Institute for Reference Materials and Measurements, Geel, Belgium., Cross NC; 1] National Genetics Reference Laboratory (Wessex), Salisbury District Hospital, Salisbury, UK [2] Faculty of Medicine, University of Southampton, Southampton, UK., Emons H; European Commission, Joint Research Centre, Institute for Reference Materials and Measurements, Geel, Belgium.

Publikováno v: Leukemia [Leukemia] 2015 Feb; Vol. 29 (2), pp. 369-76. Date of Electronic Publication: 2014 Jul 18.

Hermansky-Pudlak syndrome: the importance of molecular subtyping.

Autor: Thielen N, Huizing M, Krabbe JG, White JG, Jansen TJ, Merle PA, Gahl WA, Zweegman S

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2010 Jul; Vol. 8 (7), pp. 1643-5. Date of Electronic Publication: 2010 Apr 30.

Correlation of minimal residual disease cell frequency with molecular genotype in patients with acute myeloid leukemia.

Autor: Hess CJ; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Feller N, Denkers F, Kelder A, Merle PA, Heinrich MC, Harlow A, Berkhof J, Ossenkoppele GJ, Waisfisz Q, Schuurhuis GJ

Publikováno v: Haematologica [Haematologica] 2009 Jan; Vol. 94 (1), pp. 46-53. Date of Electronic Publication: 2008 Nov 27.